Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age

Journal of Clinical Microbiology

Volumn 35, Issue 2, 1997, Pages 468-470

  Granström, Marta ^a   Tindberg, Ylva ^b   Blennow, Margareta ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SACHS CHILDREN S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SWEDEN;

EID: 0031030545     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.2.468-470.1997     Document Type: Article

References (15)

1. Adler-Shohet, F., P. Palmer, G. Reed, and K. Edwards. 1996. Prevalence of Helicobacter pylori antibodies in normal children. Pediatr. Infect. Dis. J. 15:172-174.
2. Ashorn, M., M. Mäki, M. Hällström, M. Uhari, H. K. Åkerblom, J. Viikari, and A. Miettinen. 1995. Helicobacter pylori infection in Finnish children and adolescents. A serologic cross-sectional and follow-up study. Scand. J. Gastroenterol. 30:876-879.
3. Blennow, M., M. Granström, E. Jäätmaa, and P. Olin. 1988. Primary immunization of infants with an acellular pertussis vaccine in a double-blind randomized clinical trial. Pediatrics 82:293-299.
4. Blennow, M., and M. Granström. 1989. Adverse reactions and serologic response to a booster dose of an acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine. Pediatrics 84:62-67.
5. Blennow, M., and M. Granström. 1989. Sixteen-month follow-up of antibodies to pertussis toxin after primary immunization with acellular or whole-cell vaccine. Pediatr. Infect. Dis. J. 8:621-625.
6. Blennow, M., and M. Granström. 1990. Long term serologic follow-up after pertussis immunization. Pediatr. Infect. Dis. J. 9:21-26.
7. Blennow, M., S. Hedenskog, and M. Granström. 1988. Protective effect of acellular pertussis vaccines. Eur. J. Clin. Microbiol. Infect. Dis. 7:381-383.
8. Befrits, R., M. Granström, M. Rylander, and C. Rubio. 1993. Helicobacter pylori in 205 consecutive endoscopy patients. Scand. J. Infect. Dis. 25:185-191.
9. Klein, P. D., R. H. Gillman, R. Leon-Barna, F. Diaz, E. O'Brian Smith, and D. Y. Graham. 1994. The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am. J. Gastroenterol. 89:2196-2200.
10. Lindkvist, P., T. Wadström, and J. Giesecke. 1995. Helicobacter pylori infection and foreign travel. J. Infect. Dis. 172:1135-1136.
11. Macarthur, C., N. Saunders, and W. Feldman. 1995. Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children. JAMA 273:729-734.
12. Mitchell, H. M., Y. Y. Li, P. J. Hu, Q. Liu, M. Chen, G. G. Du, Z. J. Wang, A. Lee, and S. L. Hazell. 1992. Epidemiology of Helicobacter pylori in Southern China: identification of early childhood as the critical period for acquisition. J. Infect. Dis. 166:149-153.
13. Neale, K. R., and R. P. H. Logan. 1995. The epidemiology and transmission of Helicobacter pylori infection in children. Aliment. Pharmacol. Ther. 9 (Supp. 2):77-84.
14. Oderda, G., and S. Cadranel. 1995. Pediatric Helicobacter pylori. Curr. Opinion Gastroenterol. 11(Supp. 1):42-46.
15. Parsonnet, J. 1995. The incidence of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 9(Supp. 2):45-51.